Alexandra Zimmer

10PUBLICATIONS
90CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Models of care and place of birth
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Dec 09, 2025
Circulating tumor DNA refines risk stratification of neoadjuvant therapy-resistant breast tumors.

Mark Jesus M Magbanua, Nayelis A Manon, Denise M Wolf

|Dec 08, 2025
A Phase II Pilot Study of Anti-PD-L1, Durvalumab, and a PARP Inhibitor, Olaparib in Patients With Metastatic Triple-Negative Breast Cancer With or Without Germline BRCA Mutation.

Takeo Fujii, Ashley Cimino-Mathews, Stanley Lipkowitz

|Sep 14, 2024
Datopotamab-deruxtecan in early-stage breast cancer: the sequential multiple assignment randomized I-SPY2.2 phase 2 trial.

Katia Khoury, Jane L Meisel, Christina Yau

|Jan 27, 2023
Phase I Study and Cell-Free DNA Analysis of T-DM1 and Metronomic Temozolomide for Secondary Prevention of HER2-Positive Breast Cancer Brain Metastases.

Sarah Jenkins, Wei Zhang, Seth M Steinberg

|Dec 20, 2022
Neurologic complications of breast cancer.

Sarah L P Atkins, Alexandra S Zimmer

|Sep 13, 2022
Intraperitoneal Monocytes plus IFNs as a Novel Cellular Immunotherapy for Ovarian Cancer: Mechanistic Characterization and Results from a Phase I Clinical Trial.

Daniel S Green, Franklin Ning, Anna Duemler

Pageof 2

Frequent Collaborators

4 joint publications

Stanley Lipkowitz

2 joint publications

Paula R Pohlmann

2 joint publications

Carey K Anders

2 joint publications

Claudine Isaacs